Stock listing
APGE Stock Price, News, Filings & Events — Apogee Therapeutics, Inc.
Selected listing: APGE · BOATS · USD · US
This page tracks Apogee Therapeutics, Inc.'s APGE:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following APGE:BOATS. APGE:BOATS is the stock-level entry point for investors researching Apogee Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Apogee Therapeutics, Inc. (ticker: APGE) is a publicly traded company based in the United States, with a market capitalization of approximately $10.1 billion. The company focuses on developing innovative therapeutic solutions. Apogee is committed to advancing healthcare through its research and development efforts.

- Ticker
- APGE:BOATS
- Asset type
- Stock
- Market cap
- $10.22B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Apogee Therapeutics, Inc. APGE:BOATS stock context
This page tracks Apogee Therapeutics, Inc.'s APGE:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following APGE:BOATS. APGE:BOATS is the stock-level entry point for investors researching Apogee Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Apogee Therapeutics, Inc. (ticker: APGE) is a publicly traded company based in the United States, with a market capitalization of approximately $10.1 billion. The company focuses on developing innovative therapeutic solutions. Apogee is committed to advancing healthcare through its research and development efforts.
Latest news from Apogee Therapeutics, Inc.
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio
June 22, 2026
Apogee Therapeutics to Participate in Upcoming June Conferences
May 28, 2026
Apogee Therapeutics Announces Positive 16-Week Part B Induction Dose Optimization Results from Phase 2 APEX Trial of Zumilokibart in Mode...
May 27, 2026
Apogee Therapeutics Announces $1.3 Billion Strategic Financing Collaboration with Blackstone Life Sciences to Advance Phase 3 Development...
May 27, 2026
Apogee Therapeutics to Host Conference Call to Report Part B 16-Week Data from the Phase 2 APEX Trial of Zumilokibart in Patients with Mo...
May 26, 2026
Apogee Therapeutics, Inc. earnings calls
Research Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for APGE:BOATS.
Apogee Therapeutics, Inc. company profile
View the public company page for Apogee Therapeutics, Inc. on 6ix.
Apogee Therapeutics, Inc. news
Read company news and market updates connected to Apogee Therapeutics, Inc..
Apogee Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Apogee Therapeutics, Inc..